NO20063208L - UV-stabil, flytende eller halvfast transdermal administrasjonsform omfattende en lysomfintlig aktiv ingrediens - Google Patents

UV-stabil, flytende eller halvfast transdermal administrasjonsform omfattende en lysomfintlig aktiv ingrediens

Info

Publication number
NO20063208L
NO20063208L NO20063208A NO20063208A NO20063208L NO 20063208 L NO20063208 L NO 20063208L NO 20063208 A NO20063208 A NO 20063208A NO 20063208 A NO20063208 A NO 20063208A NO 20063208 L NO20063208 L NO 20063208L
Authority
NO
Norway
Prior art keywords
active ingredient
semi
light
gels
transdermal
Prior art date
Application number
NO20063208A
Other languages
English (en)
Norwegian (no)
Inventor
Hans-Peter Podhaisky
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34486168&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20063208(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20063208L publication Critical patent/NO20063208L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO20063208A 2003-12-10 2006-07-10 UV-stabil, flytende eller halvfast transdermal administrasjonsform omfattende en lysomfintlig aktiv ingrediens NO20063208L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03028353A EP1541136A1 (de) 2003-12-10 2003-12-10 UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten
PCT/EP2004/013839 WO2005055975A2 (de) 2003-12-10 2004-12-06 Uv-licht stabile halbfeste transdermale systeme, die einen lichtempfindlichen wirkstoff und einen uv-absorber enthalten

Publications (1)

Publication Number Publication Date
NO20063208L true NO20063208L (no) 2006-07-10

Family

ID=34486168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063208A NO20063208L (no) 2003-12-10 2006-07-10 UV-stabil, flytende eller halvfast transdermal administrasjonsform omfattende en lysomfintlig aktiv ingrediens

Country Status (24)

Country Link
EP (2) EP1541136A1 (pt)
JP (1) JP2007534643A (pt)
KR (1) KR20060096512A (pt)
CN (1) CN101415402A (pt)
AR (1) AR047140A1 (pt)
AU (1) AU2004296539B2 (pt)
BR (1) BRPI0416979A (pt)
CA (1) CA2548739C (pt)
CR (1) CR8461A (pt)
EA (1) EA010239B1 (pt)
EC (1) ECSP066689A (pt)
GT (1) GT200400261A (pt)
HN (1) HN2004000525A (pt)
IL (1) IL176208A0 (pt)
MX (1) MXPA06006534A (pt)
MY (1) MY141728A (pt)
NO (1) NO20063208L (pt)
NZ (1) NZ547733A (pt)
PE (1) PE20050863A1 (pt)
SV (1) SV2006001971A (pt)
TW (1) TW200528136A (pt)
UA (1) UA85861C2 (pt)
WO (1) WO2005055975A2 (pt)
ZA (1) ZA200605632B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI395806B (zh) 2010-04-14 2013-05-11 Ind Tech Res Inst 封裝材料
WO2012031999A2 (en) * 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Low-dose transdermal patches with high drug release
US10293023B2 (en) 2013-03-15 2019-05-21 Children's Medical Center Corporation Method of altering vascular permeability and uses thereof
JP2024000555A (ja) * 2022-06-21 2024-01-09 東ソー株式会社 紫外線抑制下でのエストラジオール測定試薬の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
JP2981523B2 (ja) * 1990-11-19 1999-11-22 株式会社林原生物化学研究所 皮膚外用剤
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
ES2297892T3 (es) * 1997-08-21 2008-05-01 JOHNSON & JOHNSON CONSUMER COMPANIES, INC. Utilizacion de 17-beta-estradiol para el tratamiento de las pieles envejecidas o dañadas por el sol y/o atrofia de la piel.
JP2000292428A (ja) * 1999-04-05 2000-10-20 Umeda Jimusho:Kk 環境化学物質の内分泌攪乱活性の新規測定方法及びその装置
JP2001129566A (ja) * 1999-11-05 2001-05-15 Mitsubishi Heavy Ind Ltd 有害物質処理方法およびその装置
FR2804024B1 (fr) * 2000-01-21 2002-09-13 Menarini France Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
FR2834895B1 (fr) * 2002-01-22 2006-06-23 Ellipse Pharmaceuticals Compositions dermatologiques, resistantes a l'eau, avec filtres solaires, procede de fabrication et utilisations de ces compositions
ITFI20020144A1 (it) * 2002-08-01 2004-02-02 Menarini Farma Ind Formulazioni topiche stabilizzate contenenti ketoprofene.

Also Published As

Publication number Publication date
AR047140A1 (es) 2006-01-11
TW200528136A (en) 2005-09-01
WO2005055975A2 (de) 2005-06-23
ZA200605632B (en) 2008-06-25
CA2548739A1 (en) 2005-06-23
WO2005055975A3 (de) 2009-03-12
MY141728A (en) 2010-06-15
CA2548739C (en) 2009-08-18
AU2004296539A1 (en) 2005-06-23
IL176208A0 (en) 2006-10-05
EP1703892A2 (de) 2006-09-27
UA85861C2 (uk) 2009-03-10
BRPI0416979A (pt) 2007-02-21
GT200400261A (es) 2005-10-31
MXPA06006534A (es) 2006-08-01
CN101415402A (zh) 2009-04-22
HN2004000525A (es) 2010-09-17
EA010239B1 (ru) 2008-06-30
PE20050863A1 (es) 2005-11-02
NZ547733A (en) 2010-02-26
AU2004296539B2 (en) 2008-10-09
KR20060096512A (ko) 2006-09-11
EA200601084A1 (ru) 2006-12-29
JP2007534643A (ja) 2007-11-29
EP1541136A1 (de) 2005-06-15
CR8461A (es) 2006-12-07
SV2006001971A (es) 2006-02-15
ECSP066689A (es) 2006-10-31

Similar Documents

Publication Publication Date Title
FI78235B (fi) Foerfarande foer framstaellning av en topisk anti-inflammatorisk komposition i gelsalvaform.
RU96120210A (ru) Гель для лечения кожных заболеваний и для дезинфекции кожи
ES2176502T3 (es) Derivados de hidroxilamina utiles para mejorar la pproduccion de chaperonas moleculares su su preparacion.
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
EA200800161A1 (ru) Новые фармацевтические композиции с модифицированным высвобождением и способ получения таких композиций
NO954329D0 (no) Forbedrede farmasöytisk akseptable blandinger inneholdende en alkohol og et hydrofobt legemiddel
TR199903053T2 (xx) Benzimidazol t�revleri.
RU94046143A (ru) Фармацевтическая композиция для лечения глаукомы
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
EP0104037A1 (en) Antiinflammatory and analgesic gel
ATE15596T1 (de) Pharmazeutische mittel.
DK0763017T3 (da) N-(3-amino-2-hydroxybutyl)sulfonamidderivater som HIV-proteaseinhibitorer
BRPI0311511A8 (pt) "preparações farmacêuticas líquidas, e sua aplicação".
EA200702319A1 (ru) Фармацевтические лекарственные формы, содержащие липидную фазу
KR960705563A (ko) 펜벤다졸 제형(Fenbendazole formulations)
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
KR880007060A (ko) 제약 조성물
AR029154A1 (es) Una tableta de liberacion controlada que comprende betahistina y un proceso para la preparacion de dicha tableta
EA200601084A1 (ru) Стабильная к ультрафиолетовым лучам жидкая или полутвёрдая форма для трансдермального введения, включающая фоточувствительный активный ингредиент
EA200101240A1 (ru) Использование мелатонина в медицине
DK1326592T3 (da) Anvendelse af polyethylenglycol (PEG) til fremstilling af et lægemiddel til behandling af forstoppelse
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
AR023100A1 (es) Metodo para aumentar la estabilidad durante el almacenamiento y/o en la aplicacion de sistemas terapeuticos fotosensibles o sus componentes y forma deadministracion del mismo
RU94038546A (ru) Прополисная мазь

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application